In the multivariable Cox regression analysis, there was no observed prognostic association of ZNF331 promoter methylation status with OS when adjusting for other predictors of patient survival, including age, sex, performance status, tumour site, stage, node status, histologic grade, and CIMP status (p = 0.27) (Figure 1(b)). Here, ZNF331 is linked to neoplasm.